Prevention and control of chronic and respiratory viral diseases using PapMV nanoparticles.
Leclerc, Denis
7 enregistrements totalisant 2,184,101.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $2,178,021 | 6 enregistrements |
| Conseil de recherches en sciences naturelles et en génie du Canada | $6,080 | 1 enregistrement |
Enregistrements
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to: • Contribute to the global response to the 2019-nCoV outbreak; • Enhance local, national and/or internat...
The specific objectives of this funding opportunity are to: · Support the development and validation of new biomedical techniques and technologies; · Demonstrate that the technology can be transit...
Adjuvantization of SIV antigens using a novel toll like receptor 7 (TLR7) agonist: A proof of concept in non human primate.
The Centre for Research on Pandemic Preparedness and Health Emergencies will provide multi-year funding for applications that have a primary research objective on preventing, preparing for, responding...
The objectives of Stream 1 are: •Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and •Generate timely evid...
Additional funding to support trainees (students, postdoctoral researchers) and research support personnel paid trough grants to address the expectional circumstances created by the COVID-19 pandemic